Early administration of the antiparasitic drug ivermectin didn't significantly shorten time to clinical improvement in 400 adults mildly ill with COVID-19, a clinical trial today in JAMA finds.
Read more:
https://www.cidrap.umn.edu/news-perspective/2021/03/ivermectin-doesnt-speed-recovery-mild-covid-19-study-shows?source=Snapzu
No comments:
Post a Comment